Literature DB >> 2911044

Rapid blood clearance of biotinylated IgG after infusion of avidin.

V V Sinitsyn1, A G Mamontova, Y Y Checkneva, A A Shnyra, S P Domogatsky.   

Abstract

The techniques of immunotherapy and radioimmunoimaging suffer from the problem of background: intravenously injected antibodies remain in the circulation much longer than it is necessary for effective binding to the target. Various approaches, including the postinjection of second antibodies, were explored to overcome the problem with some success. The phenomenon of a 100-fold more rapid blood clearance of biotinylated immunoglobulins after postinjection of an equivalent dose of avidin is described. The concentration of 125I-labeled biotinylated IgG in the circulation of rats slowly decreased to 20% of initial in 24 hr. Avidin injection at any interval during this period induced 90-95% reduction of radioactivity in blood in 15 min. Up to 70% of the radioactivity was recovered in the liver. Avidin-induced blood clearance of biotinylated immunoglobulins may find applications in immunotherapy and radio- or nuclear magnetic resonance immunoimaging.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911044

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

1.  Accelerated Blood Clearance of Antibodies by Nanosized Click Antidotes.

Authors:  Weston J Smith; Guankui Wang; Hanmant Gaikwad; Vivian P Vu; Ernest Groman; David W A Bourne; Dmitri Simberg
Journal:  ACS Nano       Date:  2018-12-05       Impact factor: 15.881

Review 2.  Optical molecular imaging and its emerging role in colorectal cancer.

Authors:  Rahul A Sheth; Umar Mahmood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

3.  Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.

Authors:  Guozheng Liu; Shuping Dou; Xiangji Chen; Ling Chen; Xinrong Liu; Mary Rusckowski; Donald J Hnatowich
Journal:  Cancer Biother Radiopharm       Date:  2010-12       Impact factor: 3.099

4.  Quantitative Correlation of in Vivo Properties with in Vitro Assay Results: The in Vitro Binding of a Biotin-DNA Analogue Modifier with Streptavidin Predicts the in Vivo Avidin-Induced Clearability of the Analogue-Modified Antibody.

Authors:  Shuping Dou; John Virostko; Dale L Greiner; Alvin C Powers; Guozheng Liu
Journal:  Mol Pharm       Date:  2015-07-08       Impact factor: 4.939

5.  Avidin chase reduces side effects of radioimmunotherapy in nude mice bearing human colon carcinoma.

Authors:  Gui-Ping Li; Yong-Xian Wang; Kai Huang; Hui Zhang; Chun-Fu Zhang
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

6.  Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.

Authors:  Mikako Ogawa; Nobuyuki Kosaka; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

Review 7.  Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis.

Authors:  Gustav J Strijkers; Ewelina Kluza; Geralda A F Van Tilborg; Daisy W J van der Schaft; Arjan W Griffioen; Willem J M Mulder; Klaas Nicolay
Journal:  Angiogenesis       Date:  2010-06       Impact factor: 9.596

8.  Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes.

Authors:  Geralda A F van Tilborg; Willem J M Mulder; Daisy W J van der Schaft; Chris P M Reutelingsperger; Arjan W Griffioen; Gustav J Strijkers; Klaas Nicolay
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

Review 9.  A semiempirical model of tumor pretargeting.

Authors:  Guozheng Liu; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

Review 10.  Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions.

Authors:  R M Reilly; J Sandhu; T M Alvarez-Diez; S Gallinger; J Kirsh; H Stern
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.